Clarify Pharma (AQSE:PSYC) Revenue : £ Mil (TTM As of . 20)

View and export this data going back to 2021. Start your Free Trial

What is Clarify Pharma Revenue?

Clarify Pharma's revenue for the six months ended in . 20 was £0.00 Mil. Clarify Pharma does not have enough years/quarters to calculate its revenue for the trailing twelve months (TTM) ended in . 20. Clarify Pharma's Revenue per Share for the six months ended in . 20 was £0.00. Clarify Pharma does not have enough years/quarters to calculate its Revenue per Share for the trailing twelve months (TTM) ended in . 20.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

Clarify Pharma Revenue Historical Data

The historical data trend for Clarify Pharma's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clarify Pharma Revenue Chart

Clarify Pharma Annual Data

Trend

Revenue

Clarify Pharma Semi-Annual Data

Revenue

Competitive Comparison of Clarify Pharma's Revenue

For the Biotechnology subindustry, Clarify Pharma's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clarify Pharma's Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clarify Pharma's Revenue distribution charts can be found below:

* The bar in red indicates where Clarify Pharma's Revenue falls into.

Clarify Pharma Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Clarify Pharma (AQSE:PSYC) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

Clarify Pharma Revenue Related Terms

Thank you for viewing the detailed overview of Clarify Pharma's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Clarify Pharma (AQSE:PSYC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clarify Pharma PLC (AQSE:PSYC) » Definitions » Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

16 Great Queen Street, 9th Floor, London, GBR, WC2B 5DG

Website

https://www.clarifypharma.com

Clarify Pharma PLC is engaged in performing research or producing neuro-pharmaceutical drug development platforms that advance medicines through science and clinical trials. Its mission is to nurture the scientific advancement of mental, emotional, psychological, and physical health by investing in alternative therapies, modalities, and sciences.